Quick Takeaways
- Panacea Innovation Ltd filed SCHEDULE 13D/A for Connect Biopharma Holdings Limited Ordinary Shares (CNTB).
- Disclosed ownership: 22%.
- Date of event: 24 Nov 2025.
Quoteable Key Fact
"Panacea Innovation Ltd disclosed 22% ownership in Connect Biopharma Holdings Limited Ordinary Shares (CNTB) on 24 Nov 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Panacea Innovation Limited | 22% | 12,000,000 | 0 | 12,000,000 | /s/ James Huang | James Huang, Founding Managing Partner | 0002010692 |
| Panacea Venture Healthcare Fund II, L.P. | 22% | 12,000,000 | 0 | 12,000,000 | By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang | James Huang, Founding Managing Partner | 0001869939 |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 22% | 12,000,000 | 0 | 12,000,000 | /s/ James Huang | James Huang, Founding Managing Partner | |
| James Huang | 22% | 12,000,000 | 0 | 12,000,000 | /s/ James Huang | James Huang | 0001573160 |